Germany's Cannabis Club Licensing Crisis Threatens Medical Patient Access

Germany's ambitious cannabis social club licensing program faces significant implementation challenges, with less than 60% of nearly 900 applications approved as clubs struggle with regulatory hurdles, location restrictions, and financial barriers. Simultaneously, medical cannabis patients confront new reimbursement restrictions from insurance providers that could force tens of thousands to discontinue treatment, pay out-of-pocket, or seek alternative therapies. The dual crisis reflects tensions between Germany's decriminalization efforts and practical enforcement inconsistencies across regions. These policy reversals particularly impact patients treating chronic conditions who previously accessed cannabis through medical channels. The situation highlights ongoing gaps between legislative intent and real-world implementation in European cannabis regulation.